Skip to main content
TLSI logo
TLSI
(NASDAQ)
TriSalus Life Sciences, Inc.
$4.24-- (--)
Loading... - Market loading

TriSalus Life Sciences (TLSI) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

TriSalus Life Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for TriSalus Life Sciences, Inc. (TLSI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents20.448.5311.7811.789.41250.214.49
Cash & Short-Term Investments20.448.5311.7811.789.41250.214.49
Accounts Receivable6.565.093.553.551.561.360.62
Inventory3.084.052.552.551.471.290.57
Other Current Assets2.173.012.992.994.772.180.41
Total Current Assets32.2420.6720.8620.8617.210.536.08
Non-Current Assets
Property, Plant & Equipment (Net)2.672.883.273.273.611.801.26
Long-Term Investments0.400.350.000.000.250.000.00
Intangible Assets0.000.000.000.000.800.790.74
Other Non-Current Assets0.020.420.470.470.120.120.05
Total Non-Current Assets3.093.303.743.744.782.712.05
Total Assets35.3323.9724.6024.6022.00250.538.13
Current Liabilities
Accounts Payable3.002.273.393.394.951.300.61
Short-Term Debt0.170.430.350.000.370.0042.18
Current Portion of Long-Term Debt0.000.000.000.000.000.0042.18
Accrued Liabilities5.684.870.0010.533.154.976.73
Other Current Liabilities8.330.3810.950.3927.040.105.22
Total Current Liabilities11.5010.2314.6914.6932.366.3754.75
Non-Current Liabilities
Long-Term Debt34.2722.081.241.241.590.000.00
Other Non-Current Liabilities23.4216.2235.7335.730.370.563.54
Total Non-Current Liabilities57.6939.6436.9836.981.96161.073.54
Total Liabilities69.1949.8751.6651.6634.3217.2558.29
Stockholders' Equity
Common Stock0.000.000.000.000.000.010.01
Retained Earnings-330.58-279.55-249.50-249.50-186.36-136.34-107.50
Additional Paid-in Capital296.72253.65222.44222.4410.036.731.36
Shares Outstanding50.0031.280.0026.4126.3226.320.00
Total Stockholders' Equity-33.86-25.89-27.07-27.07-12.32233.28-50.16
Total Liabilities & Equity35.3323.9724.6024.6022.0037.848.13

Frequently Asked Questions About TriSalus Life Sciences Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is TLSI's debt level?

Review TriSalus Life Sciences's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.